Cargando…
Anticancer activity of the protein kinase C modulator HMI‐1a3 in 2D and 3D cell culture models of androgen‐responsive and androgen‐unresponsive prostate cancer
Prostate cancer is one of the most common cancers in men. Although it has a relatively high 5‐year survival rate, development of resistance to standard androgen‐deprivation therapy is a significant clinical problem. Therefore, novel therapeutic strategies are urgently needed. The protein kinase C (P...
Autores principales: | Jäntti, Maria H., Talman, Virpi, Räsänen, Kati, Tarvainen, Ilari, Koistinen, Hannu, Tuominen, Raimo K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929934/ https://www.ncbi.nlm.nih.gov/pubmed/29744295 http://dx.doi.org/10.1002/2211-5463.12419 |
Ejemplares similares
-
Scaffold hopping from (5-hydroxymethyl) isophthalates to multisubstituted pyrimidines diminishes binding affinity to the C1 domain of protein kinase C
por: Provenzani, Riccardo, et al.
Publicado: (2018) -
3D Scanning of the Forearm for Orthosis and HMI Applications
por: Perry, Joel C., et al.
Publicado: (2021) -
Expanding the Paradigm
of Structure-Based Drug Design:
Molecular Dynamics Simulations Support the Development of New Pyridine-Based
Protein Kinase C-Targeted Agonists
por: Lautala, Saara, et al.
Publicado: (2023) -
People and the HMI of the Future
por: Kellermann, Timm, et al.
Publicado: (2020) -
Androgen regulation of the androgen receptor coregulators
por: Urbanucci, Alfonso, et al.
Publicado: (2008)